Beavis summerising my day
Here's your Friday close summary ⏬
As of Friday's close (markets open in ~65 hours ☕):
📈 S&P 500: +0.64%
📈 Nasdaq-100: +0.46%
📈 Dow Jones: +0.99%
📈 TSX Composite: +1.50%
📈 Your portfolio: +2.14%
Friday's session was a genuine split-screen day 📺 — tech rebounded and lifted indices, but beneath the surface oil 🛢️ was the real story. WTI settled near $92 and Brent cracked $104 after Trump announced a deal with Putin to release Russian diesel into global markets, easing some of the acute supply pressure but keeping prices elevated. [ref:1] Consumer sentiment also tumbled to 46.3, the second lowest reading on record — a flashing yellow light on the macro dashboard. [ref:1]
The telecom sector got absolutely torched 📡 Friday. SpaceX announced a deal to acquire a nationwide spectrum portfolio, sending Verizon down nearly 9% — its worst single day since 2002 — while AT&T and T-Mobile also fell on competition fears. [ref:1] It didn't hit you directly (your telecom weights are tiny), but it's a good reminder of how quickly a single competitor move can reprice a whole sector.
The other headline that's hard to ignore: 💉 Moderna surged after the NYT reported the NIH is launching a public-private push on personalized cancer vaccines starting in December. Moderna is already developing one with Merck and is now up more than 600% this year, making it the S&P 500's best performer. [ref:1]
Your portfolio 💪 absolutely crushed both indices Friday, coming in at +2.14% against the TSX's +1.50% and the S&P's +0.64%. The big driver was your Materials exposure — gold and silver miners had an exceptional session on the back of geopolitical safe-haven demand and elevated precious metals prices. Your 45% tech weighting also held firm despite broader tech jitters, carried mainly by $SHHI (+2.81%) on $SHOP's strong session (+3.97% on the TSX). 🛍️
🥇 Gold and silver were the standout macro theme of the day for your book. $AEME (Agnico Eagle ETF) surged +3.88%, $ABHI (Barrick ETF) +3.93%, $ZJG +3.87%, and silver plays like $SVRS (+4.30%), $PAAS (+3.03%), and $SVR (+2.95%) all had strong sessions. With oil spiking and geopolitical tension elevated, precious metals are doing exactly what they're supposed to do in your portfolio. 💛
🤖 Palantir / $PLTE +4.34% — your top single-day gainer by move. This was Goldman Sachs-fuelled: analyst Gabriela Borges upgraded Palantir to "Buy" with a $230 price target, citing the AI market's shift toward sovereign AI systems as a key growth driver. That upgrade, layered on top of Palantir's blowout Q2 (93% revenue growth, 149% U.S. commercial growth), gave the stock a meaningful leg up. Your $PLTE ETF captured most of that move. 🚀
🇨🇦📡 $T (Telus) -3.06% — this is a deeper, ongoing story. Telus cut its quarterly dividend 55% (from $0.42 to $0.19/share) when it reported Q2, paired with a $2.1 billion writedown on Telus Digital and a sharp guidance cut. New CEO Victor Dodig is prioritizing debt reduction over income — the stock has been grinding lower all year. Your position is tiny (~$375 CAD) so the damage is minimal, but worth knowing the thesis has materially changed here. Similarly, $BCE fell nearly 5% Friday, partly caught in the telecom contagion from the U.S. spectrum news. 📉
🦑 $PNG (Kraken Robotics) -5.08% — no fresh company-specific catalyst found for Friday's drop. The stock has been volatile in recent weeks as investors digest the Covelya acquisition integration and reset from a high near $8.13 this year. The underlying thesis remains intact — $327 million in combined product orders year-to-date, strong defence sector tailwinds, and NATO underwater systems spending — but it's been a rough few months. Most analysts still have a "Buy" with average targets well above current levels. Patience seems to be the prevailing view. 🎯
🚀 $MDA (MDA Space) +3.07% — Friday's bounce came after a rough stretch. MDA has been pressured by dilution concerns following a U.S. IPO earlier this year and negative free cash flow in H1 2026. That said, the company's long-term story (satellite systems, robotics, defence) remains very much in play. Total revenue was up 48% year-over-year as of Q2 and JP Morgan maintained an Overweight with a raised price target. Earnings are expected November 13 — that could be a real catalyst either way. 📅
